Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-003472
Filing Date
2025-05-23
Accepted
2025-05-23 15:40:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4536
  Complete submission text file 0001959173-25-003472.txt   5884
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Subject) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-15024 | Film No.: 25981826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 181 MASSACHUSETTS AVE. CAMBRIDGE MA 02139
Business Address
Marshall Fiona (Reporting) CIK: 0002070012 (see all company filings)

Type: 144